Answers are grounded in this paper and cite their sources.
Engineered autophagy receptors offer a way to direct intracellular degradation toward proteins implicated in neurodegeneration. Guo and colleagues fused cytoplasm-stable antibody fragments to microtubule-associated protein 1A/1B-light chain 3 alpha (LC3A) and delivered the resulting constructs using small extracellular vesicles. Their experiments show reduced pathological tau and cytoplasmic TAR DNA-binding protein 43 (TDP-43) in neuronal cultures and reduced tau pathology in mice. A separate adeno-associated virus experiment reduces TDP-43 pathology and improves motor performance in mice. These findings connect selective cargo recognition with intracellular delivery and raise questions about how engineered autophagy receptors might be adapted to different disease contexts. Here, we discuss which pathological protein assemblies are most accessible to these receptors, how selective clearance interacts with neuronal autophagic capacity, and how intracellular exposure relates to sustained functional benefit. We consider these questions with particular attention to preserving physiological protein function and linking cargo turnover to neuronal outcomes.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: